Publications
- Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study2020 | First Faculty of Medicine
- Niraparib as maintenance therapy after primary treatment of ovarian cancer - a case report2023 | First Faculty of Medicine
- Současné indikace k léčbě inhibitory PARP u pacientek s karcinomem ovarií/vejcovodu2022 | First Faculty of Medicine
- Tumour-free distance: a novel prognostic marker in patients with early-stage cervical cancer treated by primary surgery2021 | First Faculty of Medicine
- Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial - SENTIX2021 | First Faculty of Medicine
- Central Pathology Review in SENTIX, a Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer2020 | First Faculty of Medicine
- Onkologická léčba karcinomu endometria - současná doporučení2020 | First Faculty of Medicine
- Oncological outcome of surgical management in patients with recurrent uterine cancer-a multicenter retrospective cohort study-CEEGOG EX01 Trial2019 | First Faculty of Medicine
- Olaparib v léčbě recidivujícího karcinomu ovaria2019 | First Faculty of Medicine
Loading network view...